Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guérin vaccination at first health center contact.

Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau.
The Pediatric Infectious Disease Journal (Impact Factor: 3.14). 12/2011; 31(3):306-8. DOI: 10.1097/INF.0b013e3182458289
Source: PubMed

ABSTRACT A total of 105 low-birth-weight children presenting for first vaccination were randomized to receive bacillus Calmette-Guérin (BCG) immediately or later (current practice). The mortality rate ratio for BCG was 0.17 (95% CI = 0.02-1.35) within 3 days of enrollment, 0.28 (0.06-1.37) in the first month, and 0.27 (0.07-0.98) after 2 months of age. The mortality rate ratio was 0.41 (0.14-1.18) (P = 0.098) in infancy. Administration of BCG vaccine at first contact may contribute to lower mortality.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: MMR vaccination is given to protect against measles, mumps and rubella.•RSV is an important cause of acute lower respiratory infections in young children.•MMR vaccination was associated with 22% lower rate of RSV hospital contacts.•MMR vaccination may reduce the rate or severity of RSV infection.
    Vaccine 11/2014; 33(1). DOI:10.1016/j.vaccine.2014.07.110
  • The Pediatric Infectious Disease Journal 03/2012; 31(3):308-9. DOI:10.1097/INF.0b013e3182465be8
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Measles vaccines (MV) have sex-differential effects on mortality not explained by protection against measles infection. The authors examined whether whole-cell diphtheria-tetanus-pertussis (DTP) vaccine has sex-differential and non-specific effects. DATA SOURCES AND ELIGIBILITY: Following previous reviews and a new search, the effect of DTP on mortality up to the next vaccination was assessed in all studies where DTP was given after BCG or DTP was given after MV and there was prospective follow-up after ascertainment of vaccination status. High-mortality countries in Africa and Asia. The initial observation of negative effect of DTP generated six hypotheses, which were examined in all available studies and two randomised trials reducing the time of exposure to DTP. Consistency between studies. In the first study, DTP had negative effects on survival in contrast to the beneficial effects of BCG and MV. This pattern was repeated in the six other studies available. Second, the two 'natural experiments' found significantly higher mortality for DTP-vaccinated compared with DTP-unvaccinated children. Third, the female-male mortality ratio was increased after DTP in all nine studies; in contrast, the ratio was decreased after BCG and MV in all studies. Fourth, the increased female mortality associated with high-titre measles vaccine was found only among children who had received DTP after high-titre measles vaccine. Fifth, in six randomised trials of early MV, female but not male mortality was increased if DTP was likely to be given after MV. Sixth, the mortality rate declined markedly for girls but not for boys when DTP-vaccinated children received MV. The authors reduced exposure to DTP as most recent vaccination by administering a live vaccine (MV and BCG) shortly after DTP. Both trials reduced child mortality. These observations are incompatible with DTP merely protecting against the targeted diseases. With herd immunity to whooping cough, DTP is associated with higher mortality for girls. Randomised studies of DTP are warranted to measure the true impact on survival.
    BMJ Open 05/2012; 2(3). DOI:10.1136/bmjopen-2011-000707